A trial in Missouri state court has begun over claims that NEC risks caused by Similac and Enfamil infant formula led to a newborn's intestines being partially removed to save his life.
A federal judge has set an October 28, 2025 trial date for a Cartiva lawsuit, involving claims the toe implants are defectively designed and prone to failure.
A defective design in the AngioDynamics Vortex chemo port allegedly caused the catheter to break while being removed, leaving fragments behind that cannot be removed.
